Europe Pharmaceutical Supply Chain Management Market Forecast 2023-2032

The Europe pharmaceutical supply chain management market is anticipated to grow with a CAGR of 8.87% during the forecasted period of 2023-2032. The regional market's growth is set to be propagated by the implementation of the GS1 standard in Europe, in addition to the high adoption rate of advanced technology.

MARKET INSIGHTS

The Europe pharmaceutical supply chain management market study entails the examination of the United Kingdom, Spain, Nordic Countries, Germany, France, Italy, and Rest of Europe. In Italy, the pharmaceutical industry employs over 66,500 staff in 170 sites and contributes around 2% to the nation's gross domestic product (GDP), particularly from exports. Moreover, biotechnology and biologics are two core areas of Italy's pharma expertise; these entail pharmaceuticals made from components of living creatures, like proteins generated by the body.

On the other hand, Italy also plays a key role in terms of investing in digital medical innovation, personalized medicine, and precision medicine. Accordingly, a rising number of healthcare providers are focused on digitizing their supply chains. For example, in 2022, UPS announced the acquisition of Bomi Group, an Italy-based healthcare logistics firm, in order to boost its potential to deliver cold storage medicines. The nation is a leading exporter of pharma products, as well, with 80% of domestic drugs being exported to other countries. Therefore, such factors are expected to drive the Europe pharmaceutical supply chain management market growth during the forecasting period.

COMPETITIVE INSIGHTS

Some of the major enterprises operating in the market are: Arvato Supply Chain Solutions, SAP SE, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 51604

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. INCREASING APPLICATION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
- 3.1.2. ADOPTION OF GS1 STANDARD SYSTEM
- 3.1.3. GROWING PRESSURE TO REDUCE HEALTHCARE COSTS
- 3.1.4. SURGING DEMAND FOR PHARMACEUTICALS PRODUCTS
- 3.1.5. HIGH PREVALENCE OF DRUG COUNTERFEITING IN THE PHARMA INDUSTRY
3.2. KEY RESTRAINTS
- 3.2.1. STRINGENT REGULATIONS IN HEALTHCARE DATA EXCHANGE
- 3.2.2. HIGH OPERATIONAL COSTS OF HEALTHCARE SCM SOFTWARE
- 3.2.3. TECHNICAL PROBLEMS ASSOCIATED WITH SCM SOFTWARE
- 3.2.4. SECURITY ISSUES IN WEAK SCM LINKS

4. KEY ANALYTICS

4.1. KEY TECHNOLOGY TRENDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.4. MARKET CONCENTRATION ANALYSIS
4.5. MARKET MATURITY ANALYSIS

5. MARKET BY COMPONENT

5.1. SOLUTION
- 5.1.1. TRANSPORTATION MANAGEMENT SYSTEM
- 5.1.2. PLANNING & ANALYTICS
- 5.1.3. WAREHOUSE & INVENTORY MANAGEMENT SYSTEM
- 5.1.4. PROCUREMENT & SOURCING
- 5.1.5. MANUFACTURING EXECUTION SYSTEM
5.2. SERVICE
- 5.2.1. PROFESSIONAL SERVICES
- 5.2.2. MANAGED SERVICES

6. MARKET BY DEPLOYMENT MODE

6.1. ON-PREMISE
6.2. CLOUD-BASED

7. GEOGRAPHICAL ANALYSIS

7.1. EUROPE
- 7.1.1. MARKET SIZE & ESTIMATES
- 7.1.2. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET DRIVERS
- 7.1.3. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET CHALLENGES
- 7.1.4. EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
- 7.1.5. KEY PLAYERS IN EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
- 7.1.6. COUNTRY ANALYSIS
  - 7.1.6.1. UNITED KINGDOM
  - 7.1.6.1.1. UNITED KINGDOM PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.2. GERMANY
  - 7.1.6.2.1. GERMANY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.3. FRANCE
  - 7.1.6.3.1. FRANCE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.4. ITALY
  - 7.1.6.4.1. ITALY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.5. SPAIN
  - 7.1.6.5.1. SPAIN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.6. NORDIC COUNTRIES
  - 7.1.6.6.1. NORDIC COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES
  - 7.1.6.7. REST OF EUROPE
  - 7.1.6.7.1. REST OF EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET SIZE & OPPORTUNITIES

8. COMPETITIVE LANDSCAPE

8.1. KEY STRATEGIC DEVELOPMENTS
- 8.1.1. PRODUCT LAUNCHES
- 8.1.2. PARTNERSHIPS
8.2. COMPANY PROFILES
- 8.2.1. ARVATO SUPPLY CHAIN SOLUTIONS
  - 8.2.1.1. COMPANY OVERVIEW
  - 8.2.1.2. PRODUCTS / SERVICES LIST
- 8.2.2. CARDINAL HEALTH
  - 8.2.2.1. COMPANY OVERVIEW
  - 8.2.2.2. PRODUCTS / SERVICES LIST
  - 8.2.2.3. STRENGTHS & CHALLENGES
- 8.2.3. EPICOR SOFTWARE CORPORATION
  - 8.2.3.1. COMPANY OVERVIEW
  - 8.2.3.2. PRODUCTS / SERVICES LIST
- 8.2.4. GLOBAL HEALTHCARE EXCHANGE LLC
  - 8.2.4.1. COMPANY OVERVIEW
  - 8.2.4.2. PRODUCTS / SERVICES LIST
  - 8.2.4.3. STRENGTHS & CHALLENGES
- 8.2.5. INFOR
  - 8.2.5.1. COMPANY OVERVIEW
  - 8.2.5.2. PRODUCTS / SERVICES LIST
  - 8.2.5.3. STRENGTHS & CHALLENGES
- 8.2.6. JUMP TECHNOLOGIES
  - 8.2.6.1. COMPANY OVERVIEW
  - 8.2.6.2. PRODUCTS / SERVICES LIST
- 8.2.7. LOGITAG SYSTEMS
  - 8.2.7.1. COMPANY OVERVIEW
  - 8.2.7.2. PRODUCTS / SERVICES LIST
- 8.2.8. MANHATTAN ASSOCIATES
  - 8.2.8.1. COMPANY OVERVIEW
  - 8.2.8.2. PRODUCTS / SERVICES LIST
  - 8.2.8.3. STRENGTHS & CHALLENGES
- 8.2.9. MCKESSON CORPORATION
  - 8.2.9.1. COMPANY OVERVIEW
  - 8.2.9.2. PRODUCTS / SERVICES LIST
  - 8.2.9.3. STRENGTHS & CHALLENGES
- 8.2.10. ORACLE CORPORATION
  - 8.2.10.1. COMPANY OVERVIEW
  - 8.2.10.2. PRODUCTS / SERVICES LIST
  - 8.2.10.3. STRENGTHS & CHALLENGES
- 8.2.11. SAP SE
  - 8.2.11.1. COMPANY OVERVIEW
  - 8.2.11.2. PRODUCTS / SERVICES LIST
  - 8.2.11.3. STRENGTHS & CHALLENGES
- 8.2.12. SPECTRUM HEALTH
  - 8.2.12.1. COMPANY OVERVIEW
  - 8.2.12.2. PRODUCTS / SERVICES LIST
- 8.2.13. TECSYS INC
  - 8.2.13.1. COMPANY OVERVIEW
  - 8.2.13.2. PRODUCTS / SERVICES LIST
  - 8.2.13.3. STRENGTHS & CHALLENGES
- 8.2.14. TERSO SOLUTION
  - 8.2.14.1. COMPANY OVERVIEW
  - 8.2.14.2. PRODUCTS / SERVICES LIST
  - 8.2.14.3. STRENGTHS & CHALLENGES
- 8.2.15. VIZIENT INC
  - 8.2.15.1. COMPANY OVERVIEW
  - 8.2.15.2. PRODUCTS / SERVICES LIST

Product Code: 51604

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT
TABLE 2: PRIMARY FACTORS CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS
TABLE 3: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 4: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 5: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 6: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 7: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 8: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 9: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 10: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 11: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 12: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 13: KEY PLAYERS OPERATING IN EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
TABLE 14: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET REGULATORY FRAMEWORK
TABLE 15: LIST OF PRODUCT LAUNCHES
TABLE 16: LIST OF PARTNERSHIPS

LIST OF FIGURES

FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR EUROPE
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2022
FIGURE 7: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2032 (IN $ MILLION)
FIGURE 8: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SOLUTION, IN 2022
FIGURE 9: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT SYSTEM, 2023-2032 (IN $ MILLION)
FIGURE 10: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING & ANALYTICS, 2023-2032 (IN $ MILLION)
FIGURE 11: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE & INVENTORY MANAGEMENT SYSTEM, 2023-2032 (IN $ MILLION)
FIGURE 12: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT & SOURCING, 2023-2032 (IN $ MILLION)
FIGURE 13: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION SYSTEM, 2023-2032 (IN $ MILLION)
FIGURE 14: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2032 (IN $ MILLION)
FIGURE 15: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2022
FIGURE 16: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES, 2023-2032 (IN $ MILLION)
FIGURE 17: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2032 (IN $ MILLION)
FIGURE 18: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODE, IN 2022
FIGURE 19: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2032 (IN $ MILLION)
FIGURE 20: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2032 (IN $ MILLION)
FIGURE 21: EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 22: UNITED KINGDOM PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: GERMANY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 24: FRANCE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: ITALY PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: SPAIN PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 27: NORDIC COUNTRIES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 28: REST OF EUROPE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, 2023-2032 (IN $ MILLION)